These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7520614)
1. Morphopathological findings of renal allografts under FK 506 therapy. Japanese FK 506 Study Group. Transplant Proc; 1994 Aug; 26(4):1933-6. PubMed ID: 7520614 [No Abstract] [Full Text] [Related]
2. Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. Transplant Proc; 1993 Feb; 25(1 Pt 1):624-7. PubMed ID: 7679824 [No Abstract] [Full Text] [Related]
3. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495 [No Abstract] [Full Text] [Related]
4. Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group. Transplant Proc; 1991 Dec; 23(6):3071-4. PubMed ID: 1721363 [No Abstract] [Full Text] [Related]
5. Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. Ochiai T; Ishibashi M; Fukao K; Takahashi K; Endo T; Yokoyama I; Uchida K; Ohshima S; Takahara S; Morozumi K Transplant Proc; 1995 Feb; 27(1):50-3. PubMed ID: 7533419 [No Abstract] [Full Text] [Related]
6. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. Sugito K; Morozumi K; Oikawa T Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683 [No Abstract] [Full Text] [Related]
7. Reversal of accelerated renal allograft rejection with FK 506. Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Woodle ES; Thistlethwaite JR; Gordon JH Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225 [No Abstract] [Full Text] [Related]
9. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232 [No Abstract] [Full Text] [Related]
10. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
11. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473 [No Abstract] [Full Text] [Related]
12. Clinical validity of Banff grading of chronic rejection in renal transplantation. Oh CK; Jeong HJ; Kim YS; Kim MS; Choi KH; Lee HY; Han DS; Park K Transplant Proc; 1996 Jun; 28(3):1441-2. PubMed ID: 8658731 [No Abstract] [Full Text] [Related]
13. Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. Transplant Proc; 1991 Dec; 23(6):3085-8. PubMed ID: 1721367 [No Abstract] [Full Text] [Related]
14. Japanese study of FK 506 on kidney transplantation: results of late phase II study. Transplant Proc; 1993 Feb; 25(1 Pt 1):649-54. PubMed ID: 7679831 [No Abstract] [Full Text] [Related]
15. Diagnosis of chronic rejection using peritubular and glomerular capillary lesions. Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Oda A; Fujinami T; Takeda A; Uchida K Transplant Proc; 1996 Feb; 28(1):508-11. PubMed ID: 8644331 [No Abstract] [Full Text] [Related]
16. Use of FK 506 in kidney transplantation. Moutabarrik A; Takahara S; Kokado Y; Kameoka H; Takano Y; Zaid D; Sonoda T; Okuyama A; Ishibashi M Transplant Proc; 1993 Jun; 25(3):2250-2. PubMed ID: 7685946 [No Abstract] [Full Text] [Related]
17. Treatment of acute glomerular rejection with FK 506. Woodle ES; Spargo B; Ruebe M; Charette J Clin Transplant; 1996 Jun; 10(3):266-70. PubMed ID: 8826664 [TBL] [Abstract][Full Text] [Related]
18. Influence of renal mass on chronic kidney allograft rejection in rats. Heemann UW; Azuma H; Tullius SG; Mackenzie HS; Schmid C; Brenner BM; Tilney NL Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094 [No Abstract] [Full Text] [Related]
19. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection. Marcussen N; Lai R; Olsen TS; Solez K Transplant Proc; 1996 Feb; 28(1):470-6. PubMed ID: 8644316 [No Abstract] [Full Text] [Related]
20. Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group. Transplant Proc; 1991 Dec; 23(6):3111-5. PubMed ID: 1721374 [No Abstract] [Full Text] [Related] [Next] [New Search]